Vertex Pharmaceuticals Defined Contribution Plan Expense remained flat by 0.0% to $15.78M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 20.7%, from $13.08M to $15.78M. Over 2 years (FY 2023 to FY 2025), Defined Contribution Plan Expense shows an upward trend with a 20.3% CAGR.
An increase generally correlates with higher headcount or improved benefit packages, while a decrease may signal cost-cutting or reduced matching.
The total cost recognized by the company for contributions made to employee defined contribution plans, such as 401(k) m...
Standard operating expense for all large-scale employers; usually scales with total payroll.
msft_defined_contribution_plan_expense| FY'23 | FY'24 | FY'25 | |
|---|---|---|---|
| Value | $43.60M | $52.30M | $63.10M |
| YoY Change | — | +20.0% | +20.7% |